Trials / Terminated
TerminatedNCT00227136
Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 8 (planned)
- Sponsor
- University of Western Ontario, Canada · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a research study looking at the effect of 5-Hydroxy Tryptophan (5-HTP) on urine excretion of 5-Hydroxyindolacetic acid (5-HIAA). 5-HTP is a common over the counter product that is sold in natural food stores and via the Internet. Increased levels of 5-HIAA in the urine can be found in a specific type of cancer, called carcinoid tumor. This study will examine the effect of oral 5-HTP intake on 5-HIAA excretion. Understanding this effect may help to determine which tests should be done in a patient with increased 5-HIAA excretion who's also taking 5-HTP.
Detailed description
5-HTP is a common over the counter product that is sold in natural food stores and via the Internet. It is claimed to improve sleep problems, depression, anxiety, compulsive disorders, restless leg syndrome, migraines, fibromyalgia, and low pain threshold.Increased levels of 5-HIAA in the urine can be a of a specific type of cancer, called carcinoid tumor. Urinary 5-HIAA levels can also be increased by a number of food products and drugs. Oral 5-HTP is not known as a cause of elevation of 5-HIAA in urine. However, recent information suggests that 5-HTP may cause an increase. In this study we examine the effect of oral 5-HTP intake (100 mg at bedtime for 10 days) on 5-HIAA excretion in the urine, following a prospective, double-blind placebo-controlled study design. Understanding this effect may help to determine which tests should be done in a patient with increased 5-HIAA excretion who's also taking 5-HTP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5-Hydroxy-Tryptamine |
Timeline
- Start date
- 2005-05-01
- Completion
- 2005-09-01
- First posted
- 2005-09-27
- Last updated
- 2018-04-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00227136. Inclusion in this directory is not an endorsement.